Work through the question
Keep the answers with your notes.
Ask about storage for that product.
Storage needs vary by medicine: certain peptide products must be kept cold, while others are stored at room temperature.
Use the instructions from the pharmacy and the product’s label, rather than one storage rule for every peptide.
For a warm delivery, check the affected kind of drug.
GLP-1 medicines act like a body messenger involved in appetite and blood sugar.
The FDA’s guidance checked September 17, 2026 says not to use GLP-1 medicine for injection if it arrives warm or has lacked enough refrigeration.
The concern is that inadequate cooling can affect the medicine’s quality.
Get confusing measurements explained.
Reports received by the FDA by September 26, 2026 describe measurement mistakes involving compounded semaglutide, with some cases requiring hospital care.
Arizona’s Nursing Board also published an advisory about confusing labels, added ingredients and measurement errors in compounded GLP-1 products.
Ask the pharmacist and the person who wrote the prescription to explain the label and show you what their instructions mean.
Raise pregnancy questions with the clinician.
The label for semaglutide (Ozempic), checked September 17, 2026, says to stop the medicine at least two months ahead of a planned pregnancy.
The tirzepatide (Zepbound) label checked that day says to stop when pregnancy is recognised.
The two labels give different instructions. If pregnancy or breastfeeding is relevant to your care, talk with the clinician about the exact medicine and a plan for stopping or changing it.
Know where help comes from.
Ask for the clinician’s and pharmacist’s routes for questions. Read the urgent-help page for signs that need prompt action.
Open the sources for this checklist
Use the record that matches the question you are checking.